Tim-3 signaling pathway as a novel negative mediator in lipopolysaccharide-induced endotoxic shock

Human Immunology

Volumn 75, Issue 5, 2014, Pages 470-478

  Wang, Feng ^a   Hou, Hongyan ^a   Xu, Lingqing ^a   Jane, Munanie ^a   Peng, Jing ^a   Lu, Yanjun ^a   Zhu, Yaowu ^a   Sun, Ziyong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ECALECTIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; TIM 3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALPHA INTERFERON; GALECTIN; GALECTIN 9, MOUSE; HAVCR2 PROTEIN, MOUSE; MONOCLONAL ANTIBODY; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; IN VITRO STUDY; INFLAMMATION; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SURVIVAL TIME; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MALE; METABOLISM; SEPTIC SHOCK; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; GALECTINS; INTERFERON-ALPHA; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MALE; MICE; RECEPTORS, VIRUS; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84896542597     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.02.001     Document Type: Article

References (38)

1. Stearns-Kurosawa D.J., Osuchowski M.F., Valentine C., Kurosawa S., Remick D.G. The pathogenesis of sepsis. Annu Rev Pathol 2011, 6:19.
2. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546.
3. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005, 6:1245.
4. Joller N., Peters A., Anderson A.C., Kuchroo V.K. Immune checkpoints in central nervous system autoimmunity. Immunol Rev 2012, 248:122.
5. Kanzaki M., Wada J., Sugiyama K., Nakatsuka A., Teshigawara S., Murakami K., et al. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Endocrinology 2012, 153:612.
6. He W., Fang Z., Wang F., Wu K., Xu Y., Zhou H., et al. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009, 88:782.
7. Wang F., He W., Yuan J., Wu K., Zhou H., Zhang W., et al. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl Immunol 2008, 19:12.
8. Wang F., He W., Zhou H., Yuan J., Wu K., Xu L., et al. The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft. Cell Immunol 2007, 250:68.
9. Cao Y., Zhou X., Huang X., Li Q., Gao L., Jiang L., et al. Tim-3 expression in cervical cancer promotes tumor metastasis. PLoS One 2013, 8:e53834.
10. Sakuishi K., Apetoh L., Sullivan J.M., Blazar B.R., Kuchroo V.K., Anderson A.C. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010, 207:2187.
11. Tang D., Lotze M.T. Tumor immunity times out: TIM-3 and HMGB1. Nat Immunol 2012, 13:808.
12. Wu W., Shi Y., Li S., Zhang Y., Liu Y., Wu Y., et al. Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B. Eur J Immunol 2012, 42:1180.
13. Golden-Mason L., Palmer B.E., Kassam N., Townshend-Bulson L., Livingston S., McMahon B.J., et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009, 83:9122.
14. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008, 205:2763.
15. Yang X., Jiang X., Chen G., Xiao Y., Geng S., Kang C., et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol 2013, 190:2068.
16. Koguchi K., Anderson D.E., Yang L., O'Connor K.C., Kuchroo V.K., Hafler D.A. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 2006, 203:1413.
17. Shi F., Guo X., Jiang X., Zhou P., Xiao Y., Zhou T., et al. Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. Clin Immunol 2012, 145:230.
18. Fourcade J., Sun Z., Benallaoua M., Guillaume P., Luescher I.F., Sander C., et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 2010, 207:2175.
19. Gleason M.K., Lenvik T.R., McCullar V., Felices M., O'Brien M.S., Cooley S.A., et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 2012, 119:3064.
20. Ndhlovu L.C., Lopez-Verges S., Barbour J.D., Jones R.B., Jha A.R., Long B.R., et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012, 119:3734.
21. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141.
22. Li H., Wu K., Tao K., Chen L., Zheng Q., Lu X., et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2012, 56:1342.
23. Park W.S., Jung W.K., Park S.K., Heo K.W., Kang M.S., Choi Y.H., et al. Expression of galectin-9 by IFN-gamma stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways. Biochem Biophys Res Commun 2011, 411:259.
24. Wang F., Xu J., Liao Y., Wang Y., Liu C., Zhu X., et al. Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection. Cell Immunol 2011, 269:22.
25. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885.
26. Dinges M.M., Schlievert P.M. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Infect Immun 2001, 69:1256.
27. Piliponsky A.M., Chen C.C., Rios E.J., Treuting P.M., Lahiri A., Abrink M., et al. The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis. Am J Pathol 2012, 181:875.
28. Rajan S., Vyas D., Clark A.T., Woolsey C.A., Clark J.A., Hotchkiss R.S., et al. Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis. Shock 2008, 29:483.
29. Ocuin L.M., Bamboat Z.M., Balachandran V.P., Cavnar M.J., Obaid H., Plitas G., et al. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J Leukoc Biol 2011, 89:423.
30. Hotchkiss R.S., Swanson P.E., Freeman B.D., Tinsley K.W., Cobb J.P., Matuschak G.M., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27:1230.
31. Groesdonk H.V., Wagner F., Hoffarth B., Georgieff M., Senftleben U. Enhancement of NF-kappaB activation in lymphocytes prevents T cell apoptosis and improves survival in murine sepsis. J Immunol 2007, 179:8083.
32. Lamkanfi M., Moreira L.O., Makena P., Spierings D.C., Boyd K., Murray P.J., et al. Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. Blood 2009, 113:2742.
33. Zhang Y., Zhou Y., Lou J., Li J., Bo L., Zhu K., et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care 2010, 14:R220.
34. Uchida Y., Ke B., Freitas M.C., Yagita H., Akiba H., Busuttil R.W., et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010, 139:2195.
35. Zhang Y., Ma C.J., Wang J.M., Ji X.J., Wu X.Y., Moorman J.P., et al. Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes. J Leukoc Biol 2012, 91:189.
36. Mujib S., Jones R.B., Lo C., Aidarus N., Clayton K., Sakhdari A., et al. Antigen-independent induction of Tim-3 expression on human T cells by the common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway. J Immunol 2012, 188:3745.
37. Sergejeva S., Ivanov S., Lotvall J., Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol 2005, 33:248.
38. Frisancho-Kiss S., Nyland J.F., Davis S.E., Barrett M.A., Gatewood S.J., Njoku D.B., et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006, 176:6411.